Share on StockTwits

Shares of Aetna (NYSE:AET) have earned a consensus rating of “Buy” from the eighteen brokerages that are presently covering the stock, Stock Ratings Network reports. Five analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $86.00.

Several analysts have recently commented on the stock. Analysts at Goldman Sachs downgraded shares of Aetna from a “buy” rating to a “neutral” rating in a research note on Thursday, August 7th. They now have a $88.00 price target on the stock, down previously from $94.00. Separately, analysts at Leerink Swann raised their price target on shares of Aetna from $83.00 to $90.00 in a research note on Thursday, July 31st. They now have an “outperform” rating on the stock. Finally, analysts at Barclays reiterated an “overweight” rating on shares of Aetna in a research note on Wednesday, July 30th. They now have a $95.00 price target on the stock, up previously from $87.00.

Aetna (NYSE:AET) opened at 77.64 on Monday. Aetna has a 52 week low of $60.32 and a 52 week high of $85.72. The stock has a 50-day moving average of $80.97 and a 200-day moving average of $75.40. The company has a market cap of $27.531 billion and a price-to-earnings ratio of 13.47.

Aetna (NYSE:AET) last announced its earnings results on Tuesday, July 29th. The company reported $1.69 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.61 by $0.08. The company had revenue of $14.50 billion for the quarter, compared to the consensus estimate of $13.98 billion. During the same quarter in the prior year, the company posted $1.52 earnings per share. The company’s quarterly revenue was up 25.3% on a year-over-year basis. On average, analysts predict that Aetna will post $6.58 earnings per share for the current fiscal year.

Aetna Inc (NYSE:AET), is a diversified healthcare benefits company.

Receive News & Ratings for Aetna Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.